Conmed Corp. [CNMD] stock prices are up 3.96% to $80.14 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The CNMD shares have gain 5.32% over the last week, with a monthly amount drifted -0.42%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 27, February 2024, CONMED Corporation Announces Quarterly Cash Dividend. In a post published today on Yahoo Finance, CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on February 26, 2024, payable on April 5, 2024, to all shareholders of record as of March 15, 2024.
From an analyst’s perspective:
Conmed Corp. [NYSE: CNMD] stock has seen the most recent analyst activity on February 01, 2024, when Needham reiterated its Buy rating and also boosted its price target to $129 from $119. Previously, CL King started tracking the stock with Buy rating on May 22, 2023, and set its price target to $140. On March 27, 2023, upgrade upgraded it’s rating to Overweight but maintained its price target of $124 on the stock. Wells Fargo started tracking the stock assigning a Equal Weight rating and suggested a price target of $96 on March 21, 2023. Jefferies initiated its recommendation with a Hold and recommended $85 as its price target on October 12, 2022. In a note dated October 06, 2021, Needham upgraded an Buy rating on this stock but restated the target price of $150.
The stock price of Conmed Corp. [CNMD] has been fluctuating between $74.67 and $138.47 over the past year. Currently, Wall Street analysts expect the stock to reach $108 within the next 12 months. Conmed Corp. [NYSE: CNMD] shares were valued at $80.14 at the most recent close of the market. An investor can expect a potential return of 34.76% based on the average CNMD price forecast.
Analyzing the CNMD fundamentals
The Conmed Corp. [NYSE:CNMD] reported sales of 1.24B for trailing twelve months, representing a surge of 32.45%. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.08 and Total Capital is 0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 78.21 points at the first support level, and at 76.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 81.14, and for the 2nd resistance point, it is at 82.13.
Conmed Corp. [CNMD] reported earnings per share of $1.06 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $1.11/share, meaning a difference of -$0.05 and a surprise factor of -4.50%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.9 per share as compared to estimates of $0.83 per share, a difference of $0.07 representing a surprise of 8.40%.
Ratios To Look Out For
It’s worth pointing out that Conmed Corp. [NYSE:CNMD]’s Current Ratio is 1.98. On the other hand, the Quick Ratio is 0.96, and the Cash Ratio is 0.08. Considering the valuation of this stock, the price to sales ratio is 1.99, the price to book ratio is 2.96 and price to earnings (TTM) ratio is 39.29.
Transactions by insiders
Recent insider trading involved Peters Stanley W III, President AS and AET, that happened on Dec 04 ’23 when 2300.0 shares were sold. President AS and AET, Peters Stanley W III completed a deal on Nov 07 ’23 to sell 1200.0 shares. Meanwhile, President AS and AET Peters Stanley W III sold 2000.0 shares on Sep 13 ’23.
